Curriculum

Curriculum Vitae – Pr. Francesco Parmeggiani, MD, PhD (Updated on 9 October 2020)

Personal Information

First name / Surname: Francesco Parmeggiani

Mobile / Telephone: (0039) 347 4441707

E-mail: francesco.parmeggiani@unife.it or prmfnc@unife.it

Certified e-mail (PEC): francesco.parmeggiani.zniv@fe.omceo.it

Nationality: Italian

Date of Birth: 28 October 1967

ORCID iD: 0000-0002-9296-0986

Professional Sector

Medical Doctor (MD); Ophthalmologist; Associate Professor of Ophthalmology

Education and Training

in 1986, High School Certificate of Education at the Scientific High School "Antonio Roiti" of Ferrara (Italy)
in 1992, Degree of Medicine and Surgery at the University of Ferrara (Italy)
in 1992, Professional Habilitation as Medical Doctor (Certification n. 01633 - 11 February 1993 at the Medical Doctor Association of the Province of Ferrara, Italy)
in 1997, Certificate of Postgraduate Specialization in Ophthalmology at the University of Ferrara (Italy)
in 2000, Master in "Rehabilitation of low vision adult patient" at the University "Tor Vergata" of Rome (Italy)
in 2004, Degree of Philosophical Doctor (PhD) in "Disabling diseases secondary to inherited and environmental risk factors" at the University of Ferrara (Italy)

Current Working Positions

Associate Professor in Ophthalmology at the Department of Morphology, Experimental Medicine and Surgery (University of Ferrara, Italy)
Ophthalmologist at the Eye Clinic of the University Hospital of Ferrara (Azienda Ospedaliero Universitaria di Ferrara, Italy)
Scientific Referent of the Department of Morphology, Experimental Medicine and Surgery of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region - Civil Hospital of Camposampiero, Healthcare Provider ULSS 6, Padova, Italy (established by Veneto Regional Council Deliberation n. 4095/2003)
Scientific Representative of the Center for Retinitis Pigmentosa of the Veneto Region at ERN-EYE European Reference Network for the care of people with rare eye diseases (procedure n. 2014/287/EU of European Commission validated by the European Reference Network Board of EU Member States on 15 December 2016)
Principal Investigator of the Ordinary Project of Finalized National Research RF-2016-02362267 (Italian Ministry of Health; CTS of 6 December 2017)

Main Areas of Research

clinical governance of the macular diseases
clinics and genetics of inherited retinal dystrophies
pharmacogenetics of neovascular macular degenerations

Main Areas of Expertise

retinal diseases
low-vision and vision rehabilitation
glaucoma

Professional Experiences

from 1995 to 1996, Medical Officer of the Italian Air Force at the Military Airport of the 5° Air Force of Cervia (Ravenna, Italy)
from 1998 to 1999, Ophthalmologist at several First-level Outpatient Services of Healthcare Providers of Emilia-Romagna Region (Italy) and Veneto Region (Italy)
from 1999 to 2000, Ophthalmologist of the Healthcare Project entitled "Low Vision - Retinitis Pigmentosa" and supported by Veneto Region at the Ophthalmology Unit of the Civil Hospital of Camposampiero, Healthcare Provider ULSS 15, Padova (Italy)
from 2001 to 2003, PhD student in "Disabling diseases secondary to inherited and environmental risk factors" at the University of Ferrara (Italy)
from 2001 to 2008, Head of the Low Vision - Retinitis Pigmentosa Service at the Ophthalmology Unit of the Civil Hospital of Camposampiero, Healthcare Provider ULSS 15, Padova (Italy)
from 2001 to 2008, Ophthalmologist of Refractive Surgery Service at the Ophthalmology Unit of the Civil Hospital of Camposampiero, Healthcare Provider ULSS 15, Padova (Italy)
from 2004 to 2007, Research Grants on "Effectiveness profile e safety of topical drugs used in the treatment of chronic glaucoma" at the University of Ferrara (Italy)
from 2004 to 2008, Head of the Center for Retinitis Pigmentosa of the Veneto Region at the Ophthalmology Unit of the Civil Hospital of Camposampiero, Healthcare Provider ULSS 15, Padova, Italy
from 2008 to 2015, Researcher / Assistant Professor at the Eye Clinic of the University of Ferrara, engaged as Ophthalmologist at the University Hospital of Ferrara (Azienda Ospedaliero Universitaria di Ferrara, Italy) – from 1 November 2008 to 30 August 2015
from 2015, Associate Professor at the Eye Clinic of the University of Ferrara, engaged as Ophthalmologist at the University Hospital of Ferrara (Azienda Ospedaliero Universitaria di Ferrara, Italy) – from 1 September 2015 to present

Scientific Activities

from 1993, Authors of more than 120 scientific articles, of which 104 published in international indexed scientific journal (on 9 October 2020 the Author-level metrics of publication indicate an H-index equal to 22 and a total citations equal to 1734 – see http://www.scopus.com/)
in 2002, Editor of the scientific book entitled "Clinical and rehabilitative managements of low-vision patient"; Francesco Parmeggiani, Elisabeth Milan and Piero Steindler Eds. (2002); Fabiano Editore, Canelli (Asti, Italy)
from 2006, Reviewer of over 110 scientific articles for indexed international journals
from 2008, Scientific Referent of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region - Civil Hospital of Camposampiero, Healthcare Provider ULSS 6, Padova, Italy (established with the Deliberation of the Veneto Regional Council n. 4095 of 30 December 2003)
in 2009, Promoter and Organizer of the Tutorial Course entitled "Degenerative diseases of the optic nerve and retina: up-to-date", qualified as event for Continuous Education in Medicine (Event Code: VEN-FOR30918; Organizer Code: VEN-ORG148) and held at Camposampiero (Padova, Italy) on 19 December 2009
from 2009, Member of the National Scientific Committee of Retina Italia Onlus Association, confederate to Retina International Non-Governmental Organization formerly known as International Retinitis Pigmentosa Association (IRPA)
in 2010, Reviewer of research projects on ocular rare diseases for the Catalan Agency for Health Technology Assessment and Research (Spain)
in 2010, Member of the Working Group on Rare Eye Diseases of the Inter-regional Area of Veneto, Emilia-Romagna, Friuli Venezia Giulia and Trentino Alto Adige, coordinated by the Rare Diseases Center of Veneto Region in order to propose therapeutic plans dedicated to patients with rare eye diseases and shared within a controlled Register System (Rare Diseases Center of Veneto Region, Epidemiology and Community Medicine Unit of the University of Padova, Padova, Italy)
in 2010, Member of the Working Group of the Emilia-Romagna Region for the drafting of the Regional Guidelines "Intravitreal therapies with anti-VEGF drugs in the treatment of the exudative maculopathy and of the neovascular glaucoma" (RER - Bologna, Italy; Deliberation of the General Direction for Health and Social Policies of the Emilia-Romagna Region n. 611/2010)
from 2010, Member of the Interdepartmental Scientific Committee of the Center Hemostasis and Thrombosis of the University of Ferrara (Italy)
from 2010 to 2011, Guest Editor of a Special Issue entitled "Clinics, Epidemiology and Genetics of Retinitis Pigmentosa" and published in an international indexed scientific journals named "Current Genomics" (ISSN: 1389-2029 - print; ISSN: 1875-5488 - online; Bentham Science Publishers, Sharjah, United Arab Emirates)
in 2011, Reviewer of research projects on ocular diseases of the retina for the Agence Nationale de la Recherche (France)
in 2012, Reviewer of research projects on ocular rare diseases for the Fighting Blindness Ireland – MRCG/HRB (Ireland)
in 2012, Reviewer of research projects on ocular rare diseases for the E-Rare / ERA-Net (European Commission EU-FP7)
from 2012 to 2013, Member of the Editorial Board of the international scientific indexed journal named "World Journal of Pharmacology" (ISSN: 2220-3192)
from 2013 to 2016, Member of the Scientific Commission 06 (Medical and Surgical Sciences) for the evaluation of the funding requests proposed in the local context of the University of Ferrara (Italy)
from 2014 to 2015, Member of the Editorial Board of the international scientific indexed journal named "Jacobs Journal of Ophthalmology" (ISSN: 2469-3057)
from 2015 to 2016, Member of the Editorial Board of the international scientific indexed journal named "Ophthalmology Open Journal" (ISSN: 2475-1278)
from 2015 to 2016, Member of the Editorial Board of the international scientific indexed journal named "International Journal of Ophthalmology & Vision Research" (ISSN: 2640-5660)
from 2017 to 2018, Member of the Editorial Board of the international scientific journal named "EC Ophthalmology" (National Library of Medicine / NLM ID: 101704160)
from 2017, Scientific Representative of the Center for Retinitis Pigmentosa of Veneto Region at ERN-EYE European Reference Network for the care of people with rare eye diseases (procedure n. 2014/287/EU of European Commission validated by European Reference Network Board of EU Member States on 15 December 2016)
in 2018, Expert for the evaluation of Projects related to the funding applications for additional PhD scholarships of the National Operational Program (PON) Research and Innovation 2014-2020 (ANVUR - National Agency for the Evaluation of Universities and Research Institutes)
in January 2020, National Scientific Habilitation to Full Professor in Ophthalmology (working position authorized from 14 Jan 2020 to 14 Jan 2029 - Call 2018-2020 of the Italian Ministry of Education University and Research - Decree 1532/2016)

Memberships and Scientific Awards

from 1993 to present, Member of the Italian Society of Ophthalmology (named Società Oftalmologica Italiana - SOI)
in 2000, Winner of the "Poster of Medicine - City of Salerno" award, assigned by the Study Center "Trotula de Ruggiero" Onlus Foundation during the National Course of Updating in Pediatrics (29 September and 1 October 2000; Paestum, Salerno, Italy), for the Poster entitled "Quantitative evaluation of retinal venous tortuosity in patients with Œ≤-thalassemia major"
from 2003 to 2006, Scientific Representative nominated by the Italian Society of Ophthalmology within the Regional Committee of the IAPB (International Agency for the Prevention of Blindness Onlus) - Italian Union of the Blind and Partially Sighted of the Veneto Region (Italy)
in 2005, Finalist of the "WGA-WGC Best Poster" award, assigned by the World Glaucoma Association during the 3rd World Glaucoma Congress (6-9 July 2005; Vienna, Austria)
in 2005, Researcher / Contributor of the London Dysmorphology & Neurogenetics Databases OMIM (GENEYE Section http://www.lmdatabases.com/about_lmd.html) as first Author and corresponding Author of the scientific article entitled "Macular coloboma in siblings affected by different phenotypes of retinitis pigmentosa"
in 2007, Expert of the Matter for the Scientific Disciplinary Sector MED/30 "Visual Apparatus Diseases" - attribution of the Faculty Council of the School of Medicine and Surgery of the University of Ferrara (Italy)
in 2008, Winner of the "Genomic Pioneers" award for the outstanding contribution in the Genomics area of research - the award (assigned by Ocimum Biosolutions BV, IJsselstein - Utrecht, The Netherlands) was attributed during the International Human Genome Meeting 2008 (27-30 September 2008; Hyderabad, India)
in 2008, Finalist at the SOI Award for Scientific Research assigned by the Italian Society of Ophthalmology during the 88th SOI National Congress (26-29 November 2008, Roma, Italy)
in 2010, Researcher / Contributor of the Genetic Association Database (http://geneticassociationdb.nih.gov/) as first Author and corresponding Author of the scientific article entitled "Coagulation-balance genetic predictors for efficacy of photodynamic therapy in occult choroidal neovascularization secondary to age-related macular degeneration"
in 2011, Researcher / Contributor of the Genetic Association Database (http://geneticassociationdb.nih.gov/) as first Author and corresponding Author of the scientific article entitled "Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration"
from 2016, Scientific Representative nominated by the Italian Society of Ophthalmology within the Regional Committee of the IAPB (International Agency for the Prevention of Blindness Onlus) - Italian Union of the Blind and Partially Sighted of the Emilia-Romagna Region (Italy)
from 2017, Member of Academy of Sciences of Ferrara as Aggregate Associate in the Medical Sciences category (Decree of Nomination of the Ministry of Culture and Tourism of 24 May 2017)

Research Activities

in 1996, Co-Investigator of the Project entitled "Conventional pan-retinal photocoagulation versus low-energy pan-retinal photocoagulation for the treatment of proliferative diabetic retinopathy", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2002 to 2003, Principal Investigator of the Project entitled "Epidemiologic and phenotypic management of vision-threatening diseases characterized by genetic inheritance or risk factors" and supported by the Young Researcher Funding of the University of Ferrara (Italy)
from 2002 to 2003, Co-Investigator of the Project entitled "Retrospective and perspective assessment of the coagulation genetic mosaicism in patients with choroidal neovascularization treated with photodynamic therapy with verteporfin", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2003 to 2005, Co-Investigator of the multicenter Project entitled "Morphological and functional evaluation of the eye before and after surgical refractive correction" (Protocol: 2003069218; Program of Scientific Research of Relevant National Interest - PRIN 2003), co-financed by the Italian Ministry of Education University and Research, and completed, as multicenter study, also at the Eye Clinic of the University of Ferrara (Italy)
in 2004, Co-Investigator of the Project entitled "Effects of topical administration of latanoprost 0.005%, of travoprost 0.004%, and of timolol 0.5% and latanoprost 0.005% association on changes of intraocular pressure, ocular perfusion pressure and quantitative ocular surface parameters in patients with primary open-angle glaucoma", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
in 2005, Co-Investigator of the Project entitled "Effect of systemic administration of losartan potassium in modifications of intraocular pressure, ocular perfusion pressure, ocular blood flow and computerized perimetry parameters in patients with primary open-angle glaucoma", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2006 to 2007, Co-Investigator of the Project entitled "Effects of the interaction between nonsteroidal anti-inflammatory drugs and topical prostaglandin analogs in patients with primary open-angle glaucoma", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2008, Scientific Referent for Institutional Research of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region, established by the Deliberation of the Veneto Regional Council n. 4095 of 30 December 2003 in accordance with the proceedings scheduled by the Law n. 284/1997 "Measures for the prevention of blindness and for the visual rehabilitation and social and work integration of multi-disabled blinds" and qualified (after the endorsement of the Ministry of Health - DGPROGS-0018077 of 15 June 2016) as effective member of the ERN-EYE European Reference Network for the care of patients with rare eye disease (validated by the European Reference Network Board of EU Member States on 15 December 2016)
in 2008, Co-Investigator of the Project entitled "Epidemiologic screening study for the diagnosis of retinitis pigmentosa", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2009 to 2010, Co-Investigator of the Project entitled "Epidemiologic study for a targeted screening aimed to the biobanking of patients with retinitis pigmentosa", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2011 to 2012, Co-Investigator of the Project entitled "Clinic and genetic study of patients with high risk for neovascular maculopathy", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)
from 2011 to 2014, Local Coordinator and Substitute Principal Investigator of the Project entitled "Pharmacogenetic factors for the efficacy assessment of combined treatments in patients with choroidal neovascularization secondary to age-related macular degeneration" (Project Code: PRIN-2009NZAZSJ; Program of Scientific Research of Relevant National Interest - PRIN 2009), co-financed by the Italian Ministry of Education University and Research, and completed, as multicenter study, also at the Eye Clinic of the University of Ferrara (Italy)
from 2013 to 2014, Co-Investigator of the Project entitled "Clinic and genetic screening of patients with high risk of legal blindness related to maculopathy", supported by the Local Research Funding (FAR) of the University of Ferrara (Italy)

Healthcare activities and Clinical Research

from 2001 to 2008, Head of the Low Vision - Retinitis Pigmentosa Service at the Operative Unit of Ophthalmology of the Civil Hospital of Camposampiero (Healthcare Provider "Azienda ULSS 15", Padova, Italy), working with organizational and managerial positions, tasks and functions for the carrying out of II- or III-level outpatient activities (i.e. certifications of rare eye disease, prescriptions of aids for low-vision or blind patients, and/or management of personalized programs of vision rehabilitation) in more than 2.000 patients, and also directing the healthcare activity of Orthoptists / Assistants in Ophthalmology; since January 2004, the Low Vision - Retinitis Pigmentosa Service has been designated as operative headquarter of the Center for Retinitis Pigmentosa of the Veneto Region [established by the Deliberation of the Veneto Regional Council (DGRV) n. 4095 of 30 December 2003 in accordance with the Law n. 284/1997 "Measures for the prevention of blindness and for the visual rehabilitation and social and work integration of multi-disabled blinds"] and, as Head of the aforementioned Center, coordinator of the financial management of the funding assigned by the Ministry of Health according to the Law n. 284/1997 in the period 2005-2007 (DGRV n. 71/2005 and n. 4156/2007)
from 2001 to 2008, Ophthalmologist of the Refractive Surgery Service at the Operative Unit of Ophthalmology of the Civil Hospital of Camposampiero (Healthcare Provider "Azienda ULSS 15", Padova, Italy), working with tasks and functions of specialist healthcare for the carrying out of II- or III-level outpatient activities, i.e. pre-operative management of more than 4.000 candidates to refractive and therapeutic interventional procedures with excimer laser (PRK, PTK, LASEK, and LASIK), carrying out of more than 1.000 procedures PRK, PTK, LASEK, or LASIK, and post-operative management of more than 3.000 patients treated with PRK, PTK, LASEK or LASIK
from 2003 to 2005, Local Coordinator of the multicenter study entitled "Evaluation of intraocular pressure lowering-effect of Xalacom in patients with POAG or OH" (ClinicalTrials.gov Identifier: NCT00143208) and carried out at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy)
from 2006 to 2007, Local Coordinator of the multicenter study entitled "At six-week, multicenter, randomized, double-masked study to evaluate the efficacy and safety of two dosing regimens of travoprost 0.004% / timolol 0.5% once-daily morning dosing and once-daily evening dosing vs. dorzolamide 2% / timolol 0.5% eye drops twice daily in subjects with open-angle glaucoma or ocular hypertension" (EudraCT Number: 2005-004767-34) and carried out at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy)
from 2008, Ophthalmologist at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy) working, as University Medical Doctor, with tasks and functions in II- or III-level Outpatient Services, Hospitalization, Day-Hospital, Day-Surgery, and Eye Emergency Service, and, in particular, being employed in the: (i) pre-operative management of candidates to the intravitreal drugs administration in eyes affected by different forms of exudative macular diseases, having completed more than 3.500 visits for the patient’s take-in-charge, with responsibility of clinical governance and appropriateness of the decision-making process of the first therapeutic line; (ii) carrying out of more than 1.000 procedures of intravitreal injection in patients suffering from different forms of exudative macular diseases; (iii) carrying out of more than 800 procedures of photodynamic therapy with verteporfin in patients affected by neovascular macular degenerations; (iv) monitoring of patients treated with intravitreal injections after the diagnosis of different forms of exudative macular diseases, having carried out more than 18.000 check-up visits in the context of therapeutic pro-re-nata regimens - the above-listed activities were carried out as healthcare applied to the tutorial teaching for Medical Doctors of the School of Specialization in Ophthalmology of the University of Ferrara (Italy)
from 2008 to 2011, as Scientific Referent for the Institutional Research of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region, Study Coordinator of the Project entitled "Healthcare implementation for the clinical-rehabilitative management of patients suffering from retinitis pigmentosa or other vision-disabling diseases", completed at the Operative Unit of Ophthalmology of the Civil Hospital of Camposampiero (Healthcare Provider "Azienda ULSS 15", Padova, Italy) and co-financed by the Ministry of Health in accordance with the Law n. 284/1997 (DGRV n. 3229/2009 and n. 3420/2010)
from 2011 to 2012, Local Coordinator of the multicenter study entitled "A phase III, randomized, double-masked 6-month clinical study to compare the efficacy and safety of the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% eye drops to those of tafluprost 0.0015% and timolol 0.5% eye drops given as individual monotherapies in patients with open angle glaucoma or ocular hypertension" (EudraCT Number: 2010-022965-82) and carried out at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy)
from 2011 to 2018, as Scientific Referent for the Institutional Research of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region, Study Coordinator of the Project entitled "Healthcare continuity for the clinical-rehabilitative management of patients suffering from retinitis pigmentosa or other vision-disabling diseases", completed at the Operative Unit of Ophthalmology of the Civil Hospital of Camposampiero (Healthcare Provider "Azienda ULSS 6 Euganea" - formerly named "Azienda ULSS 15" - Padova, Italy) and co-financed by the Ministry of Health by means of the funding allocation in accordance with the Law n. 284/1997 (DGRV n. 2331/2011, n. 2454/2012, n. 2349/2013, n. 2826/2014, Deliberations of the Director of Management Unit Primary Healthcare and LEA of the Veneto Region n. 42/2016 and n. 92/2017)
from 2012 to 2015, as Scientific Referent for the Institutional Research of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region, Study Coordinator of the Project entitled "Targeted genealogic implementation for the clinical phenotyping and biobanking of patients with inherited chorioretinal degenerations" (Project Code: 330/2010), supported by the Funding for the Healthcare Research of the Veneto Region - Call 2010 (DGRV n. 1000/2012) and completed at the Operative Unit of Ophthalmology of the Civil Hospital of Camposampiero (Healthcare Provider "Azienda ULSS 15", Padova, Italy)
from 2014 to 2016, Principal Investigator of the Healthcare Research Program Region-University of the Emilia-Romagna Region (Area 2 Research for Clinical Governance) entitled "Single or combined protocols for the treatment of patients with neovascular age-related macular degeneration: compliance, risk/benefit and cost/benefit ratios" (Project Code: PRUA2-2013-00002008; ClinicalTrials.gov Identifier: NCT03552770), supported by the Funding for the Healthcare Research of the Emilia-Romagna Region - Call 2013 (Deliberation of the Emilia-Romagna Regional Council n. 1939/2013), and carried out at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy)
from 2014 to 2017, Local Principal Investigator of the multicenter study entitled "A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration of Fovista (anti PDGF-B pegylated aptamer) administered in combination with Lucentis compared to Lucentis monotherapy in subjects with subfoveal neovascular age-related macular degeneration" (EudraCT Number: 2013-002997-33) and carried out at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy)
from 2015 to 2016, Local Principal Investigator of the multicenter study entitled "A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration of Fovista (anti PDGF-B pegylated aptamer) administered in combination with either Avastin or Eylea compared to Avastin or Eylea monotherapy in subjects with subfoveal neovascular age-related macular degeneration" (EudraCT Number: 2013-003018-42) and carried out at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy)
from 2015 to 2019, as Scientific Referent for the Institutional Research of the University of Ferrara at the Center for Retinitis Pigmentosa of the Veneto Region, Local Coordinator of the international multicenter study entitled "Argus II retinal prosthesis system post-market surveillance study protocol" (Argus II PM-01-01; ClinicalTrials.gov Identifier NCT01490827), carried out at the Operative Unit of Ophthalmology of the Civil Hospital of Camposampiero (Healthcare Provider "Azienda ULSS 6 Euganea" - formerly named "Azienda ULSS 15" - Padova, Italy), and supported by the Veneto Region as pilot project of visual rehabilitation for the improvement of the autonomy of patients with total blindness due to retinitis pigmentosa (DGRV n. 2314/2014)
from 2019, Principal Investigator and National Coordinator of the multicenter Healthcare Research Project entitled "Patient's self-monitoring with preferential hyperacuity perimetry and unconventional tele-monitoring procedures provided by out-patient clinic services in decision-making process to determine the necessity of intravitreal retreatment with anti-angiogenic drugs in patients affected by neovascular age-related macular degeneration" (Project Code: RF-2016-02362267) and co-financed by the Ministry of Health at the Operative Unit of Ophthalmology of the University Hospital of Ferrara (Healthcare Provider "Azienda Ospedaliero Universitaria di Ferrara", Italy) in the Program of National Healthcare Research (Deliberation of the Emilia-Romagna Regional Council n. 537/2018 and subsequent Convention n. 52/RF-2016-02362267 between Ministry of Health and Emilia-Romagna Region)

Educational Activities

in 2005, Professor of the Educational Unit entitled "Educational tools and training technologies for the autonomy of visually impaired and blind people", organized by the University Center for Research, Innovation and Distance Education (CARID) of the University of Ferrara (Italy)
in the Academic Year 2007-2008, Adjunct Professor for the teaching of "Low vision and rehabilitation" in the Degree Course of Orthoptics and Ophthalmologic Assistance at the University of Ferrara (Italy)
in the Academic Year 2008-2009, Professor for the teachings of "Low vision and rehabilitation", "Electrophysiology", and "Occupational Ophthalmology" in the Degree Course of Orthoptics and Ophthalmologic Assistance at the University of Ferrara (Italy)
from the Academic Year 2008-2009, Professor for the teaching of "Visual Apparatus Diseases" at the School of Specialization in Ophthalmology of the University of Ferrara (Italy)
in the Academic Year 2009-2010, Professor for the teachings of "Low vision and rehabilitation", "Electrophysiology", "Occupational Ophthalmology", and "Semeiotics of glaucoma" in the Degree Course of Orthoptics and Ophthalmologic Assistance at the University of Ferrara (Italy)
from the Academic Year 2009-2010, Professor for the teachings of "Ophthalmology" and "Low vision and rehabilitation" in the Degree Course of Medicine and Surgery at the University of Ferrara (Italy)
from the Academic Year 2010-2011 to the Academic Year 2012-2013, Professor for the teachings of "Pathophysiology of the posterior segment", "Low vision and rehabilitation", "Electrophysiology", "Occupational Ophthalmology", and "Semeiotics of glaucoma" in the Degree Course of Orthoptics and Ophthalmologic Assistance at the University of Ferrara (Italy)
from the Academic Year 2013-2014 to the Academic Year 2017-2018, Professor for the teachings of "Rehabilitative aids and strategies in ophthalmology", "Low vision and rehabilitation", "Diagnostic tools of the vision-threatening diseases", "Occupational Ophthalmology", and "Low vision and rehabilitation" in the Degree Course of Orthoptics and Ophthalmologic Assistance at the University of Ferrara (Italy)
in 2015, Tutor during the XI National Course of the Society of University Ophthalmologists in the Section "Refractive surgery" (10-12 September 2015, Lugano, Switzerland)
from the Academic Year 2015-2016, Professor for the teaching of "Organizational contexts and healthcare promotion" in the Degree Course of Professional Education at the University of Trento (Italy)
in 2016, Tutor during the XII National Course of the Society of University Ophthalmologists in the Section "Cataract: surgery" (15-17 September 2016, Chieti, Italy)
in 2016, Visiting Professor at the University Pierre and Marie Curie, presenting a lecture entitled "Retinitis pigmentosa and age-related macular degeneration: role of inflammation in retinal cells damage" (UPMC Seminar Series / Genethon France - 18 November 2016, Evry, France)
in the Academic Year 2016-2017, Referee of PhD Theses appointed by the Faculty Board of the Doctorate Course in Biomedicine (PhD - XXIX Cycle) of the University of Padova (Italy)
in the Academic Year 2016-2017, Referee of PhD Theses appointed by the Faculty Board of the Doctorate Course in Biomedical Sciences and Translational Medicine (PhD - XXIX Cycle) of the University of Brescia (Italy)
in 2017, Tutor during the XIII National Course of the Society of University Ophthalmologists in the Section "Cataract: surgery" (14-16 September 2017, Chieti, Italy)
in the Academic Year 2017-2018, Referee of PhD Theses appointed by the Faculty Board of the Doctorate Course in Biomedicine (PhD - XXX Cycle) of the University of Padova (Italy)
in the Academic Year 2017-2018, Referee of PhD Theses appointed by the Faculty Board of the Tuscany Doctorate Course in Neuroscience (PhD - XXX Cycle) of the University of Firenze (Italy)
from 2017 to 2019, Member of the Faculty Board of Doctorate Course in Molecular Medicine (DOT1309791; PhD - XXX Cycle / XXXIII Cycle; Duration: 3 years) at the University of Ferrara (Italy)
in 2018, Tutor during the XIV National Course of the Society of University Ophthalmologists in the Section "Ocular surface and cornea " (13-18 September 2018, Chieti, Italy)
in the Academic Year 2018-2019, Referee of PhD Theses appointed by the Faculty Board of the Doctorate Course in Biomedicine (PhD - XXXI Cycle) of the University of Padova (Italy)
in the Academic Year 2018-2019, Referee of PhD Theses appointed by the Faculty Board of the Tuscany Doctorate Course in Neuroscience (PhD - XXXI Cycle) of the University of Firenze (Italy)
from the Academic Year 2018-2019, Professor for the teachings of "Ocular pathology, "Orthoptic rehabilitation", "Aids and strategies of rehabilitation of the visual disabilities", and "Advanced orthoptics" in the Degree Course of Orthoptics and Ophthalmologic Assistance at the University of Ferrara (Italy)
in 2019, Professor of the University II level Master entitled "Clinics of glaucoma" at the University of Molise, presenting the topics of "Classification of glaucoma" and "Evolution of the concept of glaucomatous disease" (A.A. 2018-2019 / UNIMOL Management - 28 March 2019, Campobasso, Italy)
in 2020, Invited speaker at the King Khaled Eye Specialist Hospital of Riyadh (Saudi Arabia) presenting a webinar lecture entitled "Role of inflammation in retinal degeneration" (KKESH Global Education Form - GEF / Retina Division - 1 July 2020)

National Scientific Publications

Incorvaia C, Parmeggiani F, Longhini L, Sensi A. Review and update on retinitis pigmentosa. L'Arcispedale Santa Anna di Ferrara XLIII/4: 265-272, 1993.
Incorvaia C, Parmeggiani F, Longhini L, De Sanctis V. Diabetic retinopathy in the course of thalassemia: longitudinal study in patients affected by beta-thalassemia major and secondary diabetes insulin-treated. Rivista di Oftalmologia I/3: 13-17, 1993.
Incorvaia C, Parmeggiani F, Longhini L, Manservigi R, Cassai E. Passive immunization with polyclonal serum in experimental herpetic keratitis. Proceedings of the LXXIII Congress of the Italian Society of Ophthalmology, Roma, Italy; 363-368; 1993.
Incorvaia C, Parmeggiani F, Longhini L. Treatment of experimental herpetic keratitis with polyclonal and monoclonal antibodies. Rivista di Oftalmologia II/2: 5-9, 1994.
De Palma P, Incorvaia C, Parmeggiani F, Longhini L. Corneal endothelium losing after extra-capsular and phacoemulsification cataract surgery. Proceedings of the LXXIV Congress of the Italian Society of Ophthalmology, Roma, Italy; 335-339; 1994.
Incorvaia C, Parmeggiani F, Longhini L. Spontaneous macular hemorrhages in the myopic degeneration. Proceedings of the S.T.U.E.M.O. Congress, Ferrara, Italy; 247-250; 1994.
Steindler P, Milan E, Parmeggiani F. Retinitis pigmentosa: early diagnosis, clinical management and rehabilitation. Proceedings of the Congress “Low vision: scientific research and rehabilitation services”, Cagliari, Italy; 32-41; 1999.
Incorvaia C, D'Angelo S, Parmeggiani F. Ophthalmologic management of juvenile diabetic retinopathy. Proceedings of the Congress "Cusanus 2000", Bressanone, Bolzano, Italy; 52-55; 2000.
Costagliola C, Parmeggiani F. The phacomatosis. Proceedings of the Congress "Cusanus 2000", Bressanone, Bolzano, Italy; 65-68; 2000.
Ferri M, Parmeggiani F, Gasparrini E, Gavioli I, Peruz G, Maciga C, Costagliola C. Topical administration of apraclonidine 0.1% and brimonidine 0.2% in patients affected by primary open-angle glaucoma: effects on ocular perfusion pressure and visual field parameters. Annali di Ottamologia e Clinica Oculistica CXXVII/4: 165-172; 2001.
Taddei Masieri L, Parmeggiani F, Gasparrini E, Gavioli I, Peruz G, Graziani F, Costagliola C. Effects of topical administration of clonidine 0.125% and brimonidine 0.2% on ocular perfusion pressure and visual field parameters in patients with primary open-angle glaucoma. Annali di Ottamologia e Clinica Oculistica CXXVII/4: 173-182; 2001.
Taddei Masieri L, Gavioli I, Parmeggiani F, Palombo B, Fogli M, Zamagni A, Costagliola C. Effects of topical administration of brinzolamide 1% on ocular perfusion pressure and visual field parameters in patients with primary open-angle glaucoma: an acute study. Annali di Ottamologia e Clinica Oculistica CXXVII/10/11: 433-444; 2001.
Parmeggiani F, Milan E, Piovan A, Sgalambro V, Mammi I, Steindler P. Vision quality and assessment of the visual function in the patients affected by disabling ocular diseases. Oftalmologia Sociale 2: 42-50, 2001.
Virgili G, Cappelli S, Giansanti F, Serafino M, Pierrottet C, Parmeggiani F, Milan E, Fasce F, Menchini U, Orzalesi N. The reading ability in patients with retinitis pigmentosa. Proceedings of the LXXXI Congress of the Italian Society of Ophthalmology, Roma, Italy; 110 (Poster Session); 2001.
Mantovani E, Parmeggiani F, Fogli M, Donadello D. Low-vision: national legislation concerning disability and rehabilitation. Oculista Italiano 132: 58-60; 2002.
Incorvaia C, Parmeggiani F. The ocular diseases. In: De Sanctis V (Ed). Medical handbook of adolescence (2nd edition), Pacini Editore, Pisa, Italy; 315-321; 2002.
Parmeggiani F, Milan E, Steindler P. The eye diseases related to the low vision drawbacks. In: Parmeggiani F, Milan E, Steindler P (Eds). Clinical and rehabilitative managements of low-vision patient. Fabiano Editore, Canelli (AT), Italy; 11-28; 2002.
Parmeggiani F. Epidemiology, diagnosis and treatment of sub-retinal neovascular complex. In: Parmeggiani F, Milan E, Steindler P (Eds). Clinical and rehabilitative managements of low-vision patient. Fabiano Editore, Canelli (AT), Italy; 29-54; 2002.
Parmeggiani F. Retinitis pigmentosa: clinic and therapeutic focusing. In: Parmeggiani F, Milan E, Steindler P (Eds). Clinical and rehabilitative managements of low-vision patient. Fabiano Editore, Canelli (AT), Italy; 81-88; 2002.
Parmeggiani F, Milan E, Piovan A. Assessment of low-vision patient. In: Parmeggiani F, Milan E, Steindler P (Eds). Clinical and rehabilitative managements of low vision patient. Fabiano Editore, Canelli (AT), Italy; 89-107; 2002.
Parmeggiani F, Steindler P. Treatment of low-vision patient. In: Parmeggiani F, Milan E, Steindler P (Eds). Clinical and rehabilitative managements of low vision patient. Fabiano Editore, Canelli (AT), Italy; 115-137; 2002.
Parmeggiani F. Quality of vision in candidate patients to refractive surgery. In: Milan E (Ed). Refractive surgery and ocular motility. Fabiano Editore, Canelli (AT), Italy; 43-55; 2002.
Pizzigoni S, Paduano B, Bettoli V, Rossi R, Parmeggiani F, Tosti G. Changes in bacteria conjunctival flora and in ocular surface of patients affected by acne and treated with oral isotretinoin. Proceedings of the 79° National Congress of the Italian Society of Dermatology, Bari, Italy; 230-231; 2004.
Parmeggiani F, Pavanello R, Piovan A. The clinical and rehabilitative problems of the low-vision patient. 15 Salute Alta Padovana 24: 16-17; 2005.
Steindler P, Parmeggiani F, De Geronimo F, De Nadai K, Milan E, Miorin S. Hereditary tapeto-retinal degenerations and cataract. Ottica Fisiopatologica 3: 237-244; 2006.
Parmeggiani F, Chizzolini M, De Nadai K, Costagliola C, Semeraro F, Sebastiani A. Clinical management of retinitis pigmentosa: up to date. Minerva Oftalmologica 52: 1-15; 2010.
De Nadai K, Chizzolini M, Allkabes M, Binotto A, Parmeggiani F. Hereditary tapeto-retinal dystrophy and degenerative myopia: intra-familial phenotypic variability in three Caucasian patients. Aggiornamenti di Terapia Oftalmologica 1: 21-29; 2010.
Parmeggiani F, Ponzin D, Carpenteri F, Bolletta E, Fresa F. Growth factors and stem cells. In: Cruciani F, Reibaldi A (Eds). Vision rehabilitation. Società Oftalmologica Italiana - SOI Editore, Roma, Italy; 161-170; 2014.

International Scientific Publications

Incorvaia C, Manservigi R, Parmeggiani F, Monini P, Longhini L, Caselli E, Cassai E. Effects of the passive transfer of anti-gB antibodies in rabbit model of HSV-1 induced keratitis. Ophthalmologica 209: 340-345, 1995.
Incorvaia C, Parmeggiani F, Mingrone G, Sebastiani A, De Sanctis V. Prevalence of retinopathy in diabetic thalassaemic patients. J Pediatr Endocrinol Metab 11: 879-883, 1998.
Incorvaia C, Lamberti G, Parmeggiani F, Ferraresi P, Calzolari E, Bernardi F, Sebastiani A. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype. Am J Ophthalmol 128: 247-248; 1999.
Bandello F, Incorvaia C, Parmeggiani F, Sebastiani A. Idiopathic multiple serous detachments of retinal pigment epithelium followed by bilateral central serous chorioretinopathy. Ophthalmologica 214: 362-367; 2000.
Caselli E, Balboni PG, Incorvaia C, Argnani R, Parmeggiani F, Cassai E, Manservigi R. Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection. Vaccine 19: 1225-1231; 2001.
Incorvaia C, Parmeggiani F, Costagliola C, Lamberti G, Ferraresi P, Bernardi F, Sebastiani A. The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. Graefes Arch Clin Exp Ophthalmol 239, 251-256; 2001.
Perri P, Incorvaia C, Costagliola C, Parmeggiani F, Lamberti G, Paduano B, Sebastiani A. Bilateral circumscribed haemangioma of the choroid not associated with systemic vascular syndrome. Br J Ophthalmol 85: 1260-1261; 2001.
Costagliola C, Del Prete A, Incorvaia C, Fusco R, Parmeggiani F, Di Giovanni A. Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 239: 809-814; 2001.
Virgili G, Parmeggiani F, Serafino M, Pierrottet C, Fasce F, Steindler P, Menchini U, Orzalesi N. Reading ability in retinitis pigmentosa: a preliminary study. Proceedings of the Annual Meeting of the Association for Research in Vision and Ophthalmology (A.R.V.O.), Fort Lauderdale, Florida, USA (Poster Section, 4597-B616). Invest Ophthalmol Vis Sci (Suppl) 42/4: S856; 2001.
Parmeggiani F, Costagliola C, Lamberti G, Incorvaia C, Perri P, Sebastiani A. Effects of 0.005% latanoprost and 0.5% timolol on circadian intraocular pressure variations in patients with normal tension glaucoma. Proceedings of the XIII Congress of European Society of Ophthalmology, Istanbul, Turkey; 270 (SP.184); 2001.
Bandello F, Incorvaia C, Rosa N, Parmeggiani F, Costagliola C, Sebastiani A. Bilateral central serous chorioretinopathy in a patient treated with systemic corticosteroids for non-Hodgkin lymphoma. Eur J Ophthalmol 12: 123-126; 2002.
Sebastiani A, Parmeggiani F, Costagliola C, Ciancaglini M, D'Oronzo E, Mastropasqua L. Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma. Acta Ophthalmol Scand (Suppl) 236: 29-30; 2002.
Ciancaglini M, Sebastiani A, Carpineto P, Costagliola C, Ciafre M, Parmeggiani F, D'Oronzo E, Mastropasqua L. Reproducibility of retinal thickness measurements with retinal thickness analyzer in healthy and glaucomatous subjects. Acta Ophthalmol Scand (Suppl) 236: 43-44; 2002.
Incorvaia C, Bandello F, Parmeggiani F, D’Angelo S, Costagliola C, Sebastiani A. Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation. Eur J Ophthalmol 12: 131-134; 2002.
Costagliola C, Del Prete A, Verolino M, Antinozzi P, Fusco R, Parmeggiani F, Mastropasqua L. Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients. Graefes Arch Clin Exp Ophthalmol 240: 379-386; 2002.
Bandello F, Incorvaia C, Parmeggiani F, D'Angelo S, Costagliola C, Sebastiani A. Management of incontinentia pigmenti: a case of monolateral preretinal fibrovascular proliferations adjacent to snail-track degeneration areas. Eur J Ophthalmol 12: 339-342; 2002.
Perri P, Paduano B, Incorvaia C, Costagliola C, Parmeggiani F, Rossi S, Lamberti G, Nenci I, Sebastiani A. Mesectodermal leiomyoma exclusively involving the posterior choroid. Am J Ophthalmol 134: 451-454; 2002.
Incorvaia C, Costagliola C, Parmeggiani F, Gemmati D, Scapoli GL, Sebastiani A. Recurrent episodes of spontaneous subconjunctival hemorrhage in patients with factor XIII Val34Leu mutation. Am J Ophthalmol 134: 927-929; 2002.
Costagliola C, Parmeggiani F, Ciancaglini M, D'Oronzo E, Mastropasqua L, Sebastiani A. Ocular perfusion pressure and visual field indexes modifications induced by alpha-agonist compound (clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2%) topical administration. an acute study on primary open-angle glaucoma patients. Ophthalmologica 217: 39-44; 2003.
Incorvaia C, Parmeggiani F, Costagliola C, Perri P, Tittoni M, Sebastiani A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency associated with bilateral keratoconus. Am J Ophthalmol 135: 557-559; 2003.
Incorvaia C, Parmeggiani F, Costagliola C, Perri P, D'Angelo S, Sebastiani A. Quantitative evaluation of the retinal venous tortuosity in chronic anemic patients affected by beta-thalassaemia major. Eye 17: 324-329; 2003.
Costagliola C, Parmeggiani F, Sebastiani A. Assessing the cost-effectiveness of switching from a beta-blocker to latanoprost in the treatment of ocular hypertension. Expert Opin Pharmacother 4: 1775-1788; 2003.
Perrotta S, Nobili B, Grassia C, Sebastiani A, Parmeggiani F, Costagliola C. Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis. Arch Ophthalmol 121: 1493-1496; 2003.
Costagliola C, Parmeggiani F, Sebastiani A. SSRIs and intraocular pressure modifications. Evidence, therapeutic implications and possible mechanisms. CNS Drugs 18: 475-484; 2004.
Parmeggiani F, Costagliola C, D'Angelo S, Incorvaia C, Perri P, Sebastiani A. Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy. A case report. Oncology-Basel 66: 502-509; 2004.
Parmeggiani F, Milan E, Costagliola C, Giuliano M, Moro A, Steindler P, Sebastiani A. Macular coloboma in siblings affected by different phenotypes of retinitis pigmentosa. Eye 18: 421-428; 2004. (data included in the London Dysmorphology & Neurogenetics Databases – Ophthalmo-Genetics or GENEEYE Section http://www.lmdatabases.com/about_lmd.html)
Parmeggiani F, Costagliola C, Incorvaia C, Gemmati D, D'Angelo S, Tognazzo S, Scapoli GL, Sebastiani A. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage. Am J Ophthalmol 138: 481-484; 2004. (data included in the Genetic Association Database – http://geneticassociationdb.nih.gov/)
Virgili G, Pierrottet C, Parmeggiani F, Pennino M, Giacomelli G, Steindler P, Menchini U, Orzalesi N. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts. Invest Ophthalmol Vis Sci 45: 3418-3424; 2004.
Gavioli I, Sebastiani A, Russo A, Casillo F, Parmeggiani F, Costagliola C. The influence of diclofenac ophthalmic solution on the intraocular pressure lowering effect of 0.005% latanoprost in glaucomatous patients. Proceedings of the European Association for Vision and Eye Research (E.V.E.R.) Meeting, Vilamoura, Portugal (Poster Session, 247). Ophthalmic Res (Suppl) 36/S1: 54; 2004.
Costagliola C, Parmeggiani F, Antinozzi PP, Caccavale A, Cotticelli L, Sebastiani A. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. Exp Eye Res 81: 610-615; 2005.
Perri P, Campa C, Incorvaia C, Parmeggiani F, Lamberti G, Costagliola C, Sebastiani A. Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patient. Mycopathologia 160: 259-261; 2005.
Parmeggiani F, Campa C, Incorvaia C, Perri P, Sebastiani A, Costagliola C. Ibuprofen oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma. Proceedings of the World Glaucoma Congress, Wien, Austria, 2005; pp 164 (P232).
Costagliola C, Parmeggiani F, Caccavale A, Sebastiani A. Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma. Am J Ophthalmol 141: 379-381; 2006.
Parmeggiani F, Costagliola C, Incorvaia C, Campa C, Gemmati D, Tognazzo S, Sebastiani A. Vision loss after PDT. Ophthalmology 113:157; 2006.
Costagliola C, Parmeggiani F. Effect of topical NSAID on IOP reduction by latanoprost. Br J Ophthalmol (e-letter); 26 June 2006.
Costagliola C, Campa C, Parmeggiani F, Incorvaia C, Perri P, D'Angelo S, Lamberti G, Sebastiani A. Carbonic anhydrase inhibitor topical application and optic nerve head blood supply in primary open-angle glaucoma patients. Proceedings of the 6th International Symposium on ocular pharmacology and therapeutics, Berlin, Germany, 2006; pp 103-106.
Costagliola C, Campa C, Parmeggiani F, Incorvaia C, Perri P, D'Angelo S, Lamberti G, Sebastiani A. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. Br J Clin Pharmacol 63: 376-379; 2007.
Costagliola C, Dell'Omo R, Prisco F, Iafusco D, Landolfo F, Parmeggiani F. Bilateral isolated acute cataracts in three newly diagnosed insulin dependent diabetes mellitus young patients. Diabetes Res Clin Pract 76: 313-315; 2007.
Parmeggiani F, Costagliola C, Gemmati D, D’Angelo S, Perri P, Scapoli GL, Catozzi L, Federici F, Sebastiani A, Incorvaia C. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age- related macular degeneration. Pharmacogenet Genomics 17: 1039-1046; 2007. (data included in the Genetic Association Database – http://geneticassociationdb.nih.gov/)
Parmeggiani F, Mantovani E, Costagliola C, Campa C, Steindler P. Total aniridia after nonperforating trauma of a pseudophakic eye: ultrasound biomicroscopic findings. J Ultrasound Med 26: 1795-1797; 2007.
Costagliola C, Parmeggiani F, Virgili G, Lamberti G, Incorvaia C, Perri P, Campa C, Sebastiani A. Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 246: 389-396; 2008.
Incorvaia C, Campa C, Parmeggiani F, Menzione M, D'Angelo S, Corte MD, Rinaldi M, Romano M, Dell'Omo R, Costagliola C. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration. Retina 29: 289-297; 2008.
Costagliola C, Campa C, Perri P, Parmeggiani F, Romano MR, Incorvaia C. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost. Curr Eye Res 33: 477-482; 2008.
Parmeggiani F, Costagliola C, Gemmati D, D'Angelo S, Perri P, Campa C, Catozzi L, Federici F, Sebastiani A, Incorvaia C. Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 3100-3106; 2008. (data included in the Genetic Association Database - http://geneticassociationdb.nih.gov/)
Costagliola C, Campa C, Incorvaia C, Parmeggiani F, Menzione M, Della Corte M, Rinaldi M, Romano M, Semeraro F. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review. Eur J Ophthalmol 18: 955-959; 2008.
Costagliola C, Parmeggiani F, Semeraro F, Sebastiani A. Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure. Curr Neuropharmacol 6: 293-310; 2008.
Campa C, Incorvaia C, D'Angelo S, Perri P, Lamberti G, Parmeggiani F, Sebastiani A. VEGF levels in the aqueous humor of patients with wet AMD treated with intravitreal bevacizumab. Proceedings of the Annual Meeting of the Association for Research in Vision and Ophthalmology (A.R.V.O.), Fort Lauderdale, Florida, USA (Poster Section, 5591-A346). Invest Ophthalmol Vis Sci 49: E-Abstract 5591; 2008.
Franco F, Parmeggiani F, Bacilieri M, Perri P, Sebastiani A. Strabismus surgery for thyroid-associated orbitopathy. Proceedings of the XIX Congress of the European Association for Cranio-Maxillo-Facial Surgery (E.A.C.M.F.S.), Bologna, Italy; Presentations O.168 (Facial reconstructive surgery I). J Craniomaxillofac Surg (Suppl) 36/1: S43; 2008.
Semeraro F, Bertazzi L, Gasparotti R, Costagliola C, Gemmati D, Catozzi L, Parmeggiani F. Multiple strokes in a newborn. Ophthalmology 116: 812-813; 2009.
Parmeggiani F, Gemmati D, Costagliola C, Sebastiani A, Incorvaia C. Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration. Pharmacogenomics 10: 81-95; 2009.
Steindler P, Mantovani E, Incorvaia C, Parmeggiani F. Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography. Graefes Arch Clin Exp Ophthalmol 247: 837-846; 2009.
Parmeggiani F, Gemmati D, Costagliola C, Sebastiani A, Incorvaia C. Predictive role of gene polymorphisms affecting thrombin-generation pathway in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration. Recent Pat DNA Gene Seq 3: 114-122; 2009.
Costagliola C, Dell'Omo R, Parmeggiani F, Romano MR, Semeraro F, Sebastiani A. Endophthalmitis. Anti-Infective Agents in Medicinal Chemistry 8: 151-168; 2009.
Costagliola C, Dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F. Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics. Expert Opin Pharmacother 10: 2663-2677; 2009.
Costagliola C, Dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F. Pharmacotherapy of intraocular pressure: part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides. Expert Opin Pharmacother 10: 2859-2870; 2009.
Costagliola C, Romano MR, Parmeggiani F, Dell'Omo R, Cultrera R. Epiretinal membrane in a 12-year-old immunocompetent girl with cytomegalovirus infection. Eur J Ophthalmol 19: 1099-1102; 2009.
Costagliola C, Romano M, Corte MD, Perrotta R, Menzione M, Rinaldi M, Semeraro F, Parmeggiani F. Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up study. Retina 29: 1227-1234; 2009.
Romano MR, Costagliola C, Dell'Omo R, Rinaldi M, Sebastiani A, Parmeggiani F. Coagulation-balance gene predictors influencing visual prognosis in patients treated with photodynamic therapy for classic choroidal neovascularization secondary to age-related macular degeneration. Proceedings of the Annual Meeting of the Association for Research in Vision and Ophthalmology (A.R.V.O.), Fort Lauderdale, Florida, USA (Poster Section, 1599-D1047). Invest Ophthalmol Vis Sci 50: E-Abstract 1599; 2009.
Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, D'Angelo S, Perri P, Sebastiani A, Incorvaia C. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia. Ophthalmology 117: 517-523; 2010.
Campa C, Costagliola C, Incorvaia C, Sheridan C, Semeraro F, De Nadai K, Sebastiani A, Parmeggiani F. Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediators Inflamm 2010: pii 546826; 2010.
Parmeggiani F, Gemmati D, Costagliola C. Thrombophilia in the occurrence of retinal vascular infarction after photodynamic therapy with verteporfin using the standard protocol. Arch Ophthalmol 128: 1632; 2010.
Romano MR, Angi M, Romano V, Parmeggiani F, Campa C, Valldeperas X, Costagliola C. Intraocular pressure changes following the use of silicone oil or Densiron 68 as endotamponade in pars plana vitrectomy. Clin Ophthalmol 4: 1391-1396; 2010.
Parmeggiani F, Costagliola C, Incorvaia C, Sebastiani A, Gemmati D. Pharmacogenetic aspects in therapeutic management of subfoveal choroidal neovascularisation: role of factor XIII-A 185 T-allele. Curr Drug Targets 12: 138-148; 2011.
Parmeggiani F. Clinics, epidemiologic and genetics of retinitis pigmentosa. Curr Genomics 12: 236-237; 2011.
Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics 12: 238-249; 2011.
Parmeggiani F, Sato G, De Nadai K, Romano MR, Binotto A, Costagliola C. Clinical and rehabilitative management of retinitis pigmentosa: up-to-date. Curr Genomics 12: 250-259; 2011.
Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genomics 12: 260-266; 2011.
Sahni JN, Angi M, Irigoyen C, Semeraro F, Romano MR, Parmeggiani F. Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy. Curr Genomics 12: 276-284; 2011.
Semeraro F, Morescalchi F, Parmeggiani F, Arcidiacono B, Costagliola C. Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration. Curr Vasc Pharmacol 9: 629-646; 2011.
Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, Perri P, D'Angelo S, Romano MR, De Nadai K, Sebastiani A, Incorvaia C. Genetic predictors of response to photodynamic therapy. Mol Diagn Ther 15: 195-210; 2011.
Romano MR, Garcia-Vallejo J, Parmeggiani F, Romano V, Vinciguerra P. Interaction between perfluorcarbon liquid and heavy silicone oil: risk factor for “sticky oil” formation. Curr Eye Res 37: 563-566; 2012.
Rinaldi M, Chiosi F, Dell'Omo R, Romano MR, Parmeggiani F, Semeraro F, Mastropasqua R, Costagliola C. Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study. Br J Clin Pharmacol 74: 940-946; 2012.
Parmeggiani F, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D’Angelo S, Perri P, De Palma P, De Nadai K, Sebastiani A. Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm 2012: pii 546786; 2012.
Perri P, Fiorica F, D'Angelo S, Lamberti G, Parmeggiani F, Martini A, Carpenteri F, Colosimo C, Micucci M, Perazzini L, De Gugliemo E, Berretta M, Sebastiani A, Cartei F. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience. Eur Rev Med Pharmacol Sci 16: 1919-1924; 2012.
Romano MR, Rinaldi M, Chiosi F, Dell'Omo R, Parmeggiani F, Semeraro F, Costagliola C. Choroidal changes in myopic eyes affected by choroidal neovascularization. Proceedings of the Annual Meeting of the Association for Research in Vision and Ophthalmology (A.R.V.O.), Fort Lauderdale, Florida, USA (Poster Section, 6924). Invest Ophthalmol Vis Sci 53: E-Abstract 6924; 2012.
Rinaldi M, Chiosi F, Dell’Omo R, Romano MR, Parmeggiani F, Semeraro F, Menzione M, Costagliola C. Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study. Retina 33: 397-402; 2013.
Semeraro F, Morescalchi F, Duse S, Parmeggiani F, Gambicorti E, Costagliola C. Aflibercept in wet AMD: specific role and optimal use. Drug Des Devel Ther 7: 711-722; 2013.
Parmeggiani F, Sorrentino FS, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D'Angelo S, Perri P, De Nadai K, Bonomo Roversi E, Franceschelli P, Sebastiani A, Rubini M. Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators Inflamm 2013: pii 435607; 2013.
Russo A, Costagliola C, Delcassi L, Parmeggiani F, Romano MR, Dell’Omo R, Semeraro F. Topical nonsteroidal anti-inflammatory drugs for macular edema. Mediators Inflamm 2013: pii 476525; 2013.
Gallenga CE, Parmeggiani F, Costagliola C, Sebastiani A, Gallenga PE. Inflammaging: should this term be suitable for age related macular degeneration too? Inflamm Res 63: 105-107; 2014.
Parmeggiani F, Costagliola C, Semeraro F, Romano MR, Rinaldi M, Gallenga CE, Gemmati D, Incorvaia C, D'Angelo S, De Nadai K, Dell’Omo Roberto, Russo A, Serino ML, Perri P. Effect of factor XIII-A C185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration. Int J Mol Sci 16: 19796-19811; 2015.
Parmeggiani F. Preferential hyperacuity perimetry: perspectives of self-monitoring of neovascular activity in patients with age-related macular degeneration. Ophthalmol Open J 1: e3-e5; 2015.
Sorrentino FS, Bonifazzi C, Parmeggiani F, Perri P. A pilot study to propose a "harm scale", a new method to predict risk of harm to the corneal endothelium caused by longitudinal phacoemulsification, and the subsequent effect of endothelial damage on post-operative visual acuity. PLoS One 11: e0146580; 2016.
Gemmati D, Vigliano M, Burini F, Mari R, El Mohsein HH, Parmeggiani F, Serino ML. Coagulation Factor XIIIA (F13A1): novel perspectives in treatment and pharmacogenetics. Curr Pharm Des 22: 1449-1459; 2016.
Parmeggiani F, De Nadai K, Tognon M. MicroRNAs as potential biomarkers and innovative therapeutic targets in retinal degenerations. Biochem Pharmacol (Los Angel) 5: 204; 2016.
Parmeggiani F, Barbaro V, De Nadai K, Lavezzo E, Toppo S, Chizzolini M, Palù G, Parolin C, Di Iorio E. Identification of novel X-linked gain-of-functionRPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia. Sci Rep 6:39179; 2016.
Parmeggiani F, Barbaro V, Migliorati A, Raffa P, Nespeca P, De Nadai K, Del Vecchio C, Palù G, Parolin C, Di Iorio E. Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation. Eur J Ophthalmol 27: 240-248; 2017.
Parmeggiani F, De Nadai K, Piovan A, Binotto A, Zamengo S, Chizzolini M. Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system. Eur J Ophthalmol 27: e16-e21; 2017.
Sorrentino FS, Matteini S, Imburgia A, Bonifazzi C, Sebastiani A, Parmeggiani F. Torsional phacoemulsification: a pilot study to revise the "harm scale" evaluating the endothelial damage and the visual acuity after cataract surgery. PLoS One 12: e0186975; 2017.
Gallenga CE, Parmeggiani F, Monari P, Perri P. Psoriatic uveitis is not an exploded myth. Clinical Dermatology 5: 118-119; 2017.
Sorrentino FS, Matteini S, Bonifazzi C, Sebastiani A, Parmeggiani F. Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction. Eye (Lond) 32: 1157-1163; 2018.
Mincarelli C, Gallenga CE, Colangelo L, Lobefalo L, Di Carlo PL, Nuri M, Parmeggiani F, Perri P. Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study. EC Ophthalmology 9.3: 119-124; 2018.
Semeraro F, Russo A, Morescalchi F, Gambicorti E, Vezzoli S, Parmeggiani F, Romano MR, Costagliola C. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study. Acta Ophthalmol 97: e97-e102; 2019.
Parmeggiani F, Gallenga CE, Costagliola C, Semeraro F, Romano MR, Dell'Omo R, Russo A, De Nadai K, Gemmati D, D'Angelo S, Bolletta E, Sorrentino FS. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration. Sci Rep 9: 2614; 2019.
Schaffrath K, Schellhase H, Walter P, Augustin A, Chizzolini M, Kirchhof B, Grisanti S, Wiedemann P, Szurman P, Richard G, Greenberg RJ, Dorn JD, Parmeggiani F, Rizzo S. One-year safety and performance assessment of the Argus II retinal prosthesis: a postapproval study. JAMA Ophthalmol 137: 896–902; 2019.
Costagliola C, Morescalchi F, Duse S, Romano D, Mazza G, Parmeggiani F, Bartollino S, Semeraro F. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. Expert Opin Drug Saf 18: 803-815; 2019.
Semeraro F, Morescalchi F, Russo A, Gambicorti E, Pilotto A, Parmeggiani F, Bartollino S, Costagliola C. Central serous chorioretinopathy: pathogenesis and management. Clin Ophthalmol 13: 2341-2352; 2019.
Bovone C, Myerscough J, Friehmann A, Elkadim M, Parmeggiani F, Busin M. Peripheral intrastromal hydration facilitates safe, deep trephination in corneas of irregular thickness. Cornea 39: 207-209; 2020.
Veritti D, Sarao V, De Nadai K, Chizzolini M, Parmeggiani F, Perissin L, Lanzetta P. Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa. J Ocul Pharmacol Ther 36: 190-197 2020.
Parmeggiani F. X-chromosome insight for targeting gene therapy. Ophthalmol Retina 4: 521-522; 2020.
Ferrara M, Allegrini D, Sorrentino T, Sborgia G, Parmeggiani F, Borgia A, Romano MR. Curcumin-based treatment for macular edema from uncommon etiologies: efficacy and safety assessment. J Med Food 23: 834-840; 2020.
Sorrentino FS, Jurman G, De Nadai K, Campa C, Furlanello C, Parmeggiani F. Application of artificial intelligence in targeting retinal diseases. Curr Drug Targets 21: 1208-1215; 2020.
Campa C, Parmeggiani F, Spena R, Ognibene D, Passerini I, Gualandi F. A novel mutation of BEST1 gene in Best disease. Eur J Ophthalmol [Epub ahead of print].
Dell'Omo R, Filippelli M, Semeraro F, Avitabile T, Giansanti F, Parmeggiani F, Romano MR, Strianese D, Romano V, Virgili G, Costagliola C. Effects of the first month of lockdown for COVID-19 in Italy: a preliminary analysis on the eyecare system from six centers. Eur J Ophthalmol [Epub ahead of print].

[Updated on 9 October 2020]

Strumenti personali

Curriculum

Università degli Studi di Ferrara

Rettrice: Prof.ssa Laura Ramaciotti